FIELD: chemistry.
SUBSTANCE: invention discloses a pharmaceutical composition which contains TAT-HOXB4 protein as an effective component. Said composition has stimulating effect on production of hematopoietic stem cells. More specifically, the recombinant protein TAT-HOXB4 enhances acceptance of intramedullary transplants, hematopoietic reconstruction, repopulation and number of circulating stem cells, specifically after chemotherapy or exposure.
EFFECT: higher protein output and stability.
24 cl, 11 dwg, 2 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION INHIBITING MEIS PROTEINS | 2017 |
|
RU2755212C2 |
| GENE THERAPY IN PATIENTS WITH FANCONI ANEMIA | 2017 |
|
RU2801241C2 |
| NON-HUMAN GENETICALLY MODIFIED ANIMALS EXPRESSING HUMAN EPO | 2015 |
|
RU2711744C1 |
| METHODS FOR GENE MODIFICATION OF HEMATOPOIETIC CELLS | 2019 |
|
RU2824194C2 |
| PREPARATION FOR INVOLVING ORIGINATING FROM BONE MARROW PLURIPOTENT STEM CELL INTO PERIPHERAL BLOOD FLOW | 2009 |
|
RU2519714C2 |
| GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO | 2015 |
|
RU2799086C2 |
| COMPOSITIONS AND METHODS FOR ENHANCING PKLR GENE EXPRESSION | 2017 |
|
RU2773358C2 |
| REPROGRAMMING HUMAN ENDOTHELIUM IN HEMATOPOIETIC PRECURSORS OF MULTIPLE LINES OF DIFFERENTIATION USING CERTAIN FACTORS | 2014 |
|
RU2691062C2 |
| METHOD FOR HIGH-EFFICIENCY COLLECTION OF FUNCTIONAL CELLS IN VIVO | 2009 |
|
RU2571230C2 |
| LENTIVIRAL VECTORS FOR PKLR DELIVERY FOR TREATMENT OF PYRUVATE KINASE DEFICIENCY | 2018 |
|
RU2777934C2 |
